
Exascale Labs fell 55.8% from $5.14 to $2.27, behind the S&P 500's −1.6%. Its worst day was Oct 23 (−28.9%), and its low came Oct 14 at $0.89.
Aug 28, 2026 – Nov 12, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-8108.26 was reported on $14.8M revenue.
−13.8% · S&P 500 −0.2%
Exascale Labs closed at its lowest level of the year, 82.7% below where the year started.
Story events cover the past 12 months · Times ET
−3.9% · S&P 500 −1.1%
Exascale Labs shares rose 73.2%, while the S&P 500 fell 1.2%.
+73.2% · S&P 500 −1.2%
Where it ended: a close of $2.27 on Nov 12, 2026. Up next: Q1 2027 earnings on Dec 15, 2026.
Nothing in the past 12 months.
All XLAB analyst actionsNothing in the past 12 months.
All XLAB dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for XLAB and SPY from Benzinga historical bars. Not investment advice.